Chularat Hospital Pcl. (SET: CHG) has announced its 2021 consolidated financial statement through the Stock Exchange of Thailand as follows;
| Yearly | 2021 | 2020 |
| Net Profit (Loss) Thousand Baht |
4,204,071 |
876,616 |
| Earning Per Share THB |
0.382 |
0.08 |
| % Change |
379.4 |
|
In 2021, the Company has revenues from hospital operations of Baht 11,742 million, increasing by Baht 6,309 million, or 116.1% YoY.
Revenue from general patients in 2021 increased by 32% YoY. The revenue from outpatients ( OPD) increased by Baht 769.87 million and inpatients ( IPD) increased by Baht 244.27 million mainly from the COVID-19 related services such as the COVID-19 screening service, the medical treatment for the COVID-19 patients since April and an additional revenue from alternative vaccination (Sinopharm & Moderna).
Revenue from Social Security scheme in 2021 increased by 6% YoY. The number of the registered member continued to increase, including additional medical treatment income from Chronic Disease (last payment of Y2020) higher than the accrued amount and an increase from adjusting the accrued amount of this revenue for the year 2021
Revenue from other governmental scheme in 2021 increased by 1,253% YoY. This is due to a significant increased revenue from the COVID-19 related services – Screening service and medical treatment in hospitals, specialized field hospital and hospitels.
Other revenue in 2021 increased by Baht 228 million from management services providing to government hospitals.
In 2021, the company’s gross profit margin increased from 32.17% to 49.91%, resulting in net profit margin increased from 16% to 35% YoY. Expenses in hospital operations increased in line with an increased revenue. The Company have an effective cost management and cost control measures while maintaining the standard and quality of medical treatment services.
